4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-24-018626
Options or other derivatives
- CEO and President acquired 285,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Stengone Carmine N. · CEO and President
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-24 | Grant or award : show line 1 in the form Stock Option (right to buy) | +285,000 | 285,000 | D |
Loading xslF345X05/rdgdoc.xml…